Quality trials and quality of life in non-small-cell lung cancer

Editorial

Peter Harper et al. J Clin Oncol. 2003.

. 2003 Aug 15;21(16):3007-8.

doi: 10.1200/JCO.2003.05.079. Epub 2003 Jul 1.

No abstract available

Comment in

Should we discard vinorelbine plus cisplatin from the first-line therapy of advanced non-small-cell lung cancer?
Dediu M. Dediu M. J Clin Oncol. 2004 Apr 1;22(7):1345-7; author reply 1347. doi: 10.1200/JCO.2004.99.228. J Clin Oncol. 2004. PMID: 15051791 No abstract available.

Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
Fossella F, Pereira JR, von Pawel J, Pluzanska A, Gorbounova V, Kaukel E, Mattson KV, Ramlau R, Szczesna A, Fidias P, Millward M, Belani CP. Fossella F, et al. J Clin Oncol. 2003 Aug 15;21(16):3016-24. doi: 10.1200/JCO.2003.12.046. Epub 2003 Jul 1. J Clin Oncol. 2003. PMID: 12837811 Clinical Trial.